Amphastar Pharmaceuticals Shares Outstanding 2012-2024 | AMPH
Amphastar Pharmaceuticals shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Amphastar Pharmaceuticals Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
53 |
| 2022 |
52 |
| 2021 |
50 |
| 2020 |
49 |
| 2019 |
50 |
| 2018 |
46 |
| 2017 |
48 |
| 2016 |
48 |
| 2015 |
45 |
| 2014 |
42 |
| 2013 |
39 |
| 2012 |
39 |
| 2011 |
39 |
| 2009 |
|
Amphastar Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-09-30 |
52 |
| 2024-06-30 |
52 |
| 2024-03-31 |
53 |
| 2023-12-31 |
53 |
| 2023-09-30 |
54 |
| 2023-06-30 |
53 |
| 2023-03-31 |
52 |
| 2022-12-31 |
52 |
| 2022-09-30 |
53 |
| 2022-06-30 |
53 |
| 2022-03-31 |
52 |
| 2021-12-31 |
50 |
| 2021-09-30 |
50 |
| 2021-06-30 |
50 |
| 2021-03-31 |
50 |
| 2020-12-31 |
49 |
| 2020-09-30 |
50 |
| 2020-06-30 |
47 |
| 2020-03-31 |
48 |
| 2019-12-31 |
50 |
| 2019-09-30 |
50 |
| 2019-06-30 |
50 |
| 2019-03-31 |
50 |
| 2018-12-31 |
46 |
| 2018-09-30 |
48 |
| 2018-06-30 |
47 |
| 2018-03-31 |
47 |
| 2017-12-31 |
48 |
| 2017-09-30 |
48 |
| 2017-06-30 |
48 |
| 2017-03-31 |
48 |
| 2016-12-31 |
48 |
| 2016-09-30 |
48 |
| 2016-06-30 |
46 |
| 2016-03-31 |
47 |
| 2015-12-31 |
45 |
| 2015-09-30 |
45 |
| 2015-06-30 |
45 |
| 2015-03-31 |
45 |
| 2014-12-31 |
42 |
| 2014-09-30 |
45 |
| 2014-06-30 |
40 |
| 2014-03-31 |
39 |
| 2013-12-31 |
39 |
| 2013-09-30 |
39 |
| 2013-06-30 |
39 |
| 2013-03-31 |
39 |
| 2012-12-31 |
39 |
| 2012-09-30 |
39 |
| 2012-06-30 |
39 |
| 2012-03-31 |
39 |
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.835B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
